Lv4
490 积分 2025-03-07 加入
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma
2小时前
待确认
LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β‐Catenin and NF‐κB signaling pathway
1天前
待确认
Enhancing phage therapy by coating single bacteriophage-infected bacteria with polymer to preserve phage vitality
16天前
已完结
A Customized Biohybrid Presenting Cascade Responses to Tumor Microenvironment
1个月前
已完结
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
1个月前
已完结
Advancement of Engineered Bacteria for Orally Delivered Therapeutics
1个月前
已完结
Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics
1个月前
已完结
Engineered oncolytic bacteria for malignant solid tumor treatment
1个月前
已完结
Living Therapeutics: Precision Diagnosis and Therapy with Engineered Bacteria
1个月前
已完结
Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)
1个月前
已完结
皖公网安备34019202002308
